The Department of Health has put out a call for researchers to undertake a national study to assess the effect of the meningitis B vaccine in preventing adolescents from carrying the meningococcal B bacteria.
Read More
GlaxoSmithKline is reporting encouraging rates of efficacy from the world’s first national meningitis B immunisation programme with Bexsero, a year after its UK launch.
Read More
Campaigners for expanding the scope of routine meningitis B vaccination in the UK say they are disappointed with a decision that a programme in infants aged one to two is not feasible.
Read More
